Healthcare/ Patients/ R&D/ R&D/ UK & Europe/ Views & Analysis/ Views & Analysis/ Views and analysis A world leader in genomics, but England’s patients face obstacles to tests Andrew McConaghie 100000 Genomes Project, Genomics England, JP Morgan 2018 0 Comment England is at the forefront of the genomics revolution – but NHS patients are unlikely to be the first to benefit. Share X A world leader in genomics, but England’s patients face obstacles to tests https://pharmaphorum.com/views-analysis-patients/world-leader-genomics-englands-patients-face-obstacles-tests/